ASTROTECH Corp
Business
Astrotech Corp commercializes its Astrotech Mass Spectrometer Technology (AMS Technology) platform via application-specific, wholly owned subsidiaries to deliver on-site and portable mass spectrometry and gas chromatography solutions. Its product portfolio includes the TRACER 1000 ETD/NTD, BreathTest-1000, AgLAB 1000 series, Pro-Control 1000, EN-SCAN instruments, plus related accessories, consumables, maintenance and software. The company operates through ATI, 1st Detect, AgLAB, BreathTech, Pro-Control and EN-SCAN business units focusing on security, agriculture, breath analysis, industrial process control and environmental testing. It distributes products to airports, cargo, border and infrastructure security, law enforcement, hemp and cannabis processors, industrial and environmental customers across the United States, Europe and Asia via direct sales, channel partners, distributors and government contracting channels.
Summary from filing dated 2025-09-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Revenue | 1 | 2 | 750,000 | 869,000 | 334,000 | |
| Cost of revenue | 574,000 | 913,000 | 444,000 | 677,000 | 298,000 | |
| Gross profit | 475,000 | 751,000 | 306,000 | 192,000 | 36,000 | |
| Selling, general and administrative | 7 | 7 | 6 | 6 | 5 | |
| Research and development | 8 | 7 | 6 | 3 | 3 | |
| Total operating expenses | 15 | 14 | 11 | 9 | 8 | |
| Loss from operations | −15 | −13 | −11 | −9 | −8 | |
| Other income and expense, net | −886,000 | −2 | 1 | 265,000 | 235,000 | |
| Loss from operations before income taxes | −14 | −12 | −10 | −8 | −8 | |
| Income tax expense | −2,000 | −2,000 | 0 | 0 | 0 | |
| Net loss | −14 | −12 | −10 | −8 | −8 | |
| Basic and diluted (in shares) | 2 | 2 | 2 | 2 | 22 | |
| Net loss per common share (in dollars per share) | −8.32 | −7.12 | −5.95 | −5.24 | −0.35 | |
| Net unrealized gain | 313,000 | 276,000 | −254,000 | −1 | −23,000 | |
| Total comprehensive loss | −14 | −11 | −10 | −10 | −8 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-08-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 3 | 10 | 14 | 26 | — | |
| Short-term investments | 15 | 21 | 28 | 26 | — | |
| Accounts receivable | 485,000 | 77,000 | 225,000 | 56,000 | — | |
| Raw materials | 2 | 2 | 1 | 864,000 | — | |
| Work-in-process | 425,000 | 66,000 | 243,000 | 136,000 | — | |
| Finished goods | 310,000 | 370,000 | 373,000 | 518,000 | — | |
| Prepaid expenses and other current assets | 353,000 | 261,000 | 365,000 | 748,000 | — | |
| Total current assets | 22 | 35 | 45 | 55 | — | |
| Property, Plant and Equipment, Net | 2 | 3 | 3 | 1 | — | |
| Intangible assets, net | 48,000 | 0 | — | — | — | |
| Operating lease assets | 2 | 119,000 | 262,000 | 162,000 | — | |
| Other assets, net | 346,000 | 30,000 | 30,000 | 11,000 | — | |
| Total assets | 27 | 38 | 48 | 56 | — | |
| Accounts payable | 1 | 373,000 | 546,000 | 169,000 | — | |
| Payroll related accruals | 529,000 | 1 | 633,000 | 816,000 | — | |
| Accrued expenses and other liabilities | 451,000 | 754,000 | 1 | 961,000 | — | |
| Operating and Finance Leases, Liability, Current | 405,000 | 227,000 | 316,000 | 234,000 | — | |
| Total current liabilities | 2 | 3 | 3 | 3 | — | |
| Accrued expenses and other liabilities, net of current portion | 164,000 | 232,000 | 0 | — | — | |
| Operating and Finance Leases, Liability, Noncurrent | 2 | 73,000 | 291,000 | 303,000 | — | |
| Total liabilities | 5 | 3 | 3 | 3 | — | |
| Commitments and contingencies (Note 13) | — | — | — | — | — | |
| Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at June 30, 2025 and 2024, respectively | 0 | 0 | 0 | 0 | — | |
| Common stock, $0.001 par value, 250,000,000 shares authorized at June 30, 2025 and 2024 respectively; 1,769,269 and 1,712,045 shares issued at June 30, 2025 and 2024 respectively; 1,758,953 and 1,701,729 shares outstanding at June 30, 2025 and 2024, respectively | 191 | 191 | 191 | 191 | — | |
| Treasury shares, 10,316 shares at June 30, 2025 and 2024, respectively | −119,000 | −119,000 | −119,000 | 0 | — | |
| Additional paid-in capital | 83 | 82 | 81 | 80 | — | |
| Accumulated deficit | −251 | −237 | −225 | −216 | — | |
| Accumulated other comprehensive loss | −864,000 | −1 | −1 | −1 | — | |
| Total stockholders equity | 22 | 35 | 45 | 53 | 3 | |
| Total liabilities and stockholders equity | 27 | 38 | 48 | 56 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Stock-based compensation | 830,000 | 1 | 1 | 2 | 626,000 | |
| Depreciation | 962,000 | 731,000 | 366,000 | 148,000 | — | |
| Amortization of operating lease right-of-use assets | 194,000 | 143,000 | 123,000 | 88,000 | — | |
| Interest on financing leases | 5,000 | 13,000 | 15,000 | 13,000 | — | |
| Loss on disposal of asset | 294,000 | 0 | 25,000 | 0 | — | |
| Accounts receivable | −408,000 | 148,000 | −169,000 | −51,000 | 96,000 | |
| Inventory, net | −455,000 | −479,000 | −477,000 | −18,000 | −824,000 | |
| Accounts payable | 693,000 | −173,000 | 377,000 | −227,000 | 157,000 | |
| Other assets and liabilities | −1 | 246,000 | 390,000 | 138,000 | −113,000 | |
| Income taxes payable | 0 | 1,000 | −2,000 | 0 | — | |
| Repayment of financing liability in connection with internal-use software | 0 | −14,000 | — | — | — | |
| Operating lease liabilities | 170,000 | −153,000 | −130,000 | −86,000 | — | |
| Net cash used in operating activities | −13 | −10 | −8 | −7 | −7 | |
| Purchases of property and equipment | −833,000 | −579,000 | −2 | −596,000 | −211,000 | |
| Purchases of intangible assets | −50,000 | 0 | — | — | — | |
| Proceeds from short-term investments | 7 | 7 | 3 | — | — | |
| Net cash provided by (used in) investing activities | 6 | 6 | −4 | −596,000 | −28 | |
| Repayment of financing liability in connection with internal-use software | −91,000 | 0 | — | — | — | |
| Repayments on finance lease liabilities | −94,000 | −181,000 | −157,000 | −95,000 | −12,000 | |
| Net cash used in financing activities | −185,000 | −181,000 | −776,000 | −2 | 68 | |
| Net change in cash and cash equivalents | −7 | −4 | −12 | −9 | 33 | |
| Cash paid for interest | 11,000 | 26,000 | 69,000 | 515,000 | 3,000 | |
| Income taxes paid | 0 | 2,000 | 2,000 | 0 | 0 | |
| Operating right-of-use interest | 10,000 | 0 | — | — | — | |
| Finance lease expenditures incurred but not paid for as of the end of the period | 7,000 | 0 | — | — | — | |
| Acquisition of equipment/ software through financing lease | 0 | 245,000 | 119,000 | 394,000 | 0 | |
| Operating right-of-use assets | 2 | 0 | — | — | — | |
| Operating right-of-use associated liabilities | 3 | 0 | — | — | — |